Product
Clostridium difficile
1 clinical trial
1 indication
Indication
Clostridium difficile infectionClinical trial
A PHASE 3, RANDOMIZED OBSERVER-BLINDED STUDY TO EVALUATE THE IMMUNOGENICITY, SAFETY, AND TOLERABILITY OF 2 DOSES COMPARED TO 3 DOSES OF CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDERStatus: Completed, Estimated PCD: 2020-12-22